🇺🇸 FDA

Company profile · Sponsor

Xeris

Xeris Biopharma Holdings

XERS · NYSE biotech CHICAGO, IL, USA
Pipeline
16
Drugs
1
Patents
8

Quick answer

Xeris (XERS) is a biotech company. headquartered in CHICAGO, IL, USA. listed on NYSE. NovaPharmaNews links 16 pipeline programs, 1 drug, and 8 patents to this profile..

Company facts

Ticker XERS
Exchange NYSE
Company type biotech
Headquarters CHICAGO, IL, USA
SEC CIK 0001867096

Pipeline (16)

Search pipeline →

  1. G-Pen

    Xeris

    Insulin Hypoglycemia

    phase 3 small molecule completed

    1 trial

  2. G-Pen (glucagon injection)

    Xeris

    Hypoglycemia

    phase 3 small molecule completed

    1 trial

  3. Glucagon

    Xeris

    Diabetes Mellitus, Type 1

    phase 3 small molecule completed

    1 trial

  4. G-Pen Mini™ (glucagon injection)

    Xeris

    Hypoglycemia

    phase 2 small molecule completed

    1 trial

  5. G-Pen Mini™ (glucagon injection)

    Xeris

    Diabetes Mellitus, Type 1

    phase 2 small molecule completed

    2 trials

  6. G-Pen(TM) 1 mg

    Xeris

    Hypoglycemia

    phase 2 small molecule completed

    1 trial

  7. G-Pump™ (glucagon infusion)

    Xeris

    Hypoglycemia

    phase 2 small molecule completed

    1 trial

  8. Glucagon

    Xeris

    Hypoglycemia

    phase 2 small molecule completed

    1 trial

  9. Glucagon

    Xeris

    Congenital Hyperinsulinism

    phase 2 small molecule completed

    1 trial

  10. Glucagon RTU

    Xeris

    Hyperinsulinemic Hypoglycemia

    phase 2 small molecule completed

    1 trial

  11. Glucagon RTU Injection With Insulin Pump Reduction

    Xeris

    Hypoglycemia

    phase 2 small molecule completed

    1 trial

  12. Novo Nordisk GlucaGen®

    Xeris

    Hypoglycemia

    phase 2 small molecule completed

    1 trial

  13. PRAM9

    Xeris

    Diabetes Mellitus, Type 1

    phase 2 small molecule completed

    1 trial

  14. glucagon

    Xeris

    Post-bariatric Hypoglycemia

    phase 2 small molecule completed

    1 trial

  15. levothyroxine sodium

    Xeris

    Hypothyroidism

    phase 2 small molecule completed

    1 trial

  16. XeriSol glucagon

    Xeris

    Type1diabetes

    phase 1 small molecule completed

    1 trial

Drugs (1)

Search drugs →

  1. dichlorphenamide

    ORMALVI

    ORAL approved

Patents (8)

Search patents →

  1. US 12377096

    Methods of treating disease with levoketoconazole

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11964003

    Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11957736

    Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11833157

    Precipitation resistant small molecule drug formulations

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11590205

    Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11576951

    Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11446310

    Stable formulations for parenteral injection of small molecule drugs

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11129940

    Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Xeris?

Xeris (XERS) is a biotech company. headquartered in CHICAGO, IL, USA. listed on NYSE. NovaPharmaNews links 16 pipeline programs, 1 drug, and 8 patents to this profile..

What pipeline programs does Xeris sponsor?

We track 16 ClinicalTrials.gov-linked programs for Xeris, including G-Pen and 15 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Xeris company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.